PMGC Holdings Inc.
Short

ELAB Parabolic gapper into supply: watching for VWAP / PMH rej.

43
TL;DR:
ELAB gapped >100% on strong pre-market volume. I’m watching pops back into $14.20–15.35 (supply from the first spike) for a lower-high + VWAP rejection. If it stuffs under those levels, I’ll scale in short with risk above $16.00–16.90 (PMH) and look for a fade toward $10 → $9 → $7.20.

Why I care

Liquidity: >10M pre-market shares traded; dollar volume >$100M = plenty of liquidity.

Extension: +100%+ gap with a vertical first leg and overhead levels at $14.23 and $15.35 (see chart).

Playbook setup: classic “gap & go → stuff → lower high under PMH/VWAP.”

Key levels (from today’s pre-market)

$16.87 – Pre-Market High (PMH)

$15.35 – Supply shelf / spike base

$14.23 – Prior pivot / mid-shelf

VWAP – dynamic; looking for rejection from above

$10.00 / $9.00 / $7.20 – downside magnets if the unwind starts

Trade plan

Conservative short idea

Wait for open price discovery and a pop into $14.20–15.35.

Look for: rejection wick, lower-high, or VWAP fail.

Entry: scale starter on weakness back below the level; add on the first lower-high.

Risk: hard stop above $16.00; emergency stop above PMH $16.87.

Targets: $10.0 → $9.0 → $7.2 (trail on new 15-min lower highs).

Aggressive scalp idea

If it spikes through $15s and instantly stuffs back below VWAP, take a quick short with tight risk 30–40c above trigger, cover partial at $11s–$10s, hold a runner only if VWAP stays overhead.

If it squeezes instead…

Reclaims $15.35 and holds VWAP as support → no short. A PMH reclaim and hold above $16.90 invalidates the bias; switch to neutral/long scalp only on pullbacks.

Risk management checklist

Size down on >100% gappers (volatility tax).

No averaging above risk line.

Respect halts; avoid chasing into halts.

If VWAP flips to support after entry, take it off.

Alerts I set

Price crossing: $14.20, $15.35, $16.00, $16.87

VWAP cross alerts (up & down)

15-min lower-high confirmation under $15

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.